4-Quinolinylboronic acid(CAS: 371764-64-6)

4-Quinolinylboronic acid (CAS: 371764-64-6) is regulated under the Globally Harmonized System (GHS) for classification and labeling of chemical substances. It is also subject to the European Union’s Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) Regulation. In the context of the United States, it must comply with regulations set by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA).

While 4-Quinolinylboronic acid (CAS: 371764-64-6) is a specific boronic acid derivative, other alternatives include 2-Quinolinylboronic acid and 3-Quinolinylboronic acid, which may offer similar functionalities in different synthetic contexts. Additionally, isomers and analogs such as 4-(1H-benzimidazol-2-yl)boronic acid can be considered depending on the specific requirements of the synthesis.

The market for 4-Quinolinylboronic acid (CAS: 371764-64-6) is driven by its use in medicinal chemistry and organic synthesis. Research trends are focusing on its application in drug discovery and development, particularly in the areas of anticancer and antiviral therapies. The demand is expected to grow with the increasing focus on novel therapeutic agents.

Waste containing 4-Quinolinylboronic acid (CAS: 371764-64-6) should be collected in appropriate, labeled containers and stored separately to prevent contamination. For disposal, professional waste disposal services should be utilized, and incineration may be necessary depending on local regulations. Environmental protection precautions include ensuring no spillage and proper handling to avoid exposure to the environment and human health.